Shibuya M
Department of Genetics, University of Tokyo, Japan.
Nihon Yakurigaku Zasshi. 1996 Mar;107(3):119-31. doi: 10.1254/fpj.107.119.
Angiogenesis is important not only in normal embryogenesis, tissue organization and its maintenance but also in pathological processes such as ocular disease in diabetes mellitus and rapid growth of tumors in vivo. Recently, endothelial cell-specific growth factor (VEGF) and its receptors (Flt family) has been characterized, and this ligand-tyrosine kinase receptor is considered to be one of the most important systems involved in angiogenesis. VEGF is induced by a variety of normal or tumor cells under conditions such as hypoxia and hypoglycemia and in the presence of substances such as hormones and growth factors. On the other hand, receptors of the Flt family (Flt-1, KDR/Flk-1, Flt-4) are basically strictly expressed only on vascular endothelial cells with a rare exception. Thus, the stimulation of VEGF-Flt towards angiogenesis is through a paracrine mechanism. A direct involvement of Flt-1 and KDR/Flk-1 in vasculogenesis/angiogenesis has recently been demonstrated by gene targetting studies. Blocking of this system might be a useful tool for suppression of solid tumors in vivo.
血管生成不仅在正常胚胎发育、组织构建及其维持过程中发挥重要作用,而且在诸如糖尿病性眼病及体内肿瘤快速生长等病理过程中也具有重要意义。最近,内皮细胞特异性生长因子(VEGF)及其受体(Flt家族)已得到明确,这种配体 - 酪氨酸激酶受体被认为是参与血管生成的最重要系统之一。VEGF在缺氧、低血糖等条件下以及在激素和生长因子等物质存在时,由多种正常细胞或肿瘤细胞诱导产生。另一方面,Flt家族的受体(Flt - 1、KDR/Flk - 1、Flt - 4)基本上仅在血管内皮细胞上严格表达,仅有极少数例外情况。因此,VEGF - Flt对血管生成的刺激是通过旁分泌机制实现的。最近的基因靶向研究已证实Flt - 1和KDR/Flk - 1直接参与血管发生/血管生成。阻断该系统可能是体内抑制实体瘤的一种有效手段。